Cardiovascular Drugs Practice Questions

Q: Propranolol can be used in all of the following conditions except?

Variant angina. **Explanation:** The correct answer is **Variant angina (Prinzmetal angina)**. Propranolol is a non-selective beta-blocker that is strictly contraindicated in this condition. **1. Why Variant Angina is the correct answer:** Variant angina is caused by **coronary artery vasospasm** rather than atherosclerosis. In the coronary vessels, there are both $\beta_2$ receptors (which cause vasodilation) and $\alpha_1$ receptors (which cause vasoconstriction). Propranolol blocks the $\beta_2$ receptors, leaving the $\alpha_1$-mediated vasoconstrictive effects **unopposed**. This can worsen the coronary spasm, potentially leading to myocardial infarction. **2. Analysis of Incorrect Options:** * **Thyrotoxicosis:** Propranolol is the drug of choice to control symptomatic tachycardia, tremors, and palpitations. It also uniquely inhibits the peripheral conversion of $T_4$ to the more active $T_3$. * **Migraine:** Propranolol is a first-line agent for the **prophylaxis** of migraine (not for acute attacks) due to its high lipid solubility and ability to cross the blood-brain barrier. * **Hypertension:** While no longer first-line for uncomplicated hypertension, beta-blockers remain an option, especially in patients with co-existing conditions like stable angina or post-MI. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Variant Angina:** Calcium Channel Blockers (CCBs) like Diltiazem or Nitrates. * **Other Contraindications for Propranolol:** Bronchial asthma/COPD (due to $\beta_2$ blockade causing bronchospasm), Bradycardia, and Second/Third-degree Heart Block. * **Metabolic effect:** Propranolol can mask the warning symptoms of hypoglycemia (tachycardia) in diabetic patients, except for sweating (which is mediated by cholinergic receptors).

Q: Which of the following is a potassium channel opener?

Nicorandil. **Explanation:** **Correct Answer: A. Nicorandil** Nicorandil is a unique anti-anginal drug with a dual mechanism of action. It acts as a **Potassium Channel Opener ($K_{ATP}$ channels)** and a **Nitric Oxide (NO) donor**. By opening ATP-sensitive $K^+$ channels in vascular smooth muscle, it causes potassium efflux, leading to hyperpolarization and subsequent closure of voltage-gated calcium channels. This results in significant **arteriolar dilation** (reducing afterload). Simultaneously, its nitrate moiety increases cGMP, causing **venous dilation** (reducing preload). This dual action effectively reduces myocardial oxygen demand and improves coronary blood flow. **Analysis of Incorrect Options:** * **B. Ranolazine:** This is a **late sodium channel blocker**. It prevents the overload of intracellular calcium via the $Na^+/Ca^{2+}$ exchanger, thereby improving myocardial relaxation and reducing wall tension without affecting heart rate or blood pressure. * **C. Ivabradine:** This drug is a selective **$I_f$ (funny) current inhibitor** in the SA node. It reduces heart rate without affecting myocardial contractility or conduction, making it a "pure" bradycardic agent. * **D. Nitroprusside:** This is a potent **vasodilator** that acts by releasing Nitric Oxide (NO). It does not act on potassium channels; it stimulates guanylyl cyclase to increase cGMP, causing both arterial and venous dilation. **High-Yield Clinical Pearls for NEET-PG:** * **Nicorandil Side Effect:** A characteristic and high-yield side effect is **persistent mucosal ulceration** (oral, anal, or perianal ulcers). * **Preconditioning:** Nicorandil mimics "ischemic preconditioning," providing a cardioprotective effect during MI. * **Other K+ Channel Openers:** Minoxidil, Diazoxide (used in hypertensive emergencies/insulinoma), and Pinacidil.

Q: Which of the following is the shortest acting beta-blocker?

Esmolol. ### Explanation **Correct Answer: D. Esmolol** **Why Esmolol is the correct answer:** Esmolol is a **cardioselective (β1)** antagonist characterized by its ultra-short duration of action. The underlying pharmacological reason is its metabolism: Esmolol contains an **ester linkage** that is rapidly hydrolyzed by **red blood cell esterases**. * **Onset of action:** 2–5 minutes. * **Elimination half-life:** Approximately **9 minutes**. This makes it ideal for "titratable" intravenous use in acute settings where rapid reversal of beta-blockade might be necessary if adverse effects occur. **Why the other options are incorrect:** * **A. Acebutolol:** A cardioselective beta-blocker with **Intrinsic Sympathomimetic Activity (ISA)**. It has a half-life of about 3–4 hours. * **B. Sotalol:** A non-selective beta-blocker that also possesses **Class III antiarrhythmic** properties (potassium channel blockade). It has a long half-life of 12 hours and is excreted unchanged by the kidneys. * **C. Bisoprolol:** A highly cardioselective beta-blocker used primarily in chronic heart failure and hypertension. It has a half-life of 9–12 hours, allowing for once-daily dosing. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for Esmolol:** Supraventricular tachycardia (SVT), intraoperative hypertension, and aortic dissection (to reduce shear stress). * **Metabolism Fact:** Because it is metabolized by RBC esterases, its clearance is independent of renal or hepatic function. * **Longest acting beta-blocker:** **Nadolol** (half-life ~20–24 hours). * **Beta-blocker with Nitric Oxide (NO) activity:** **Nebivolol** (most cardioselective) and **Carvedilol**. * **Lipid solubility:** Propranolol is highly lipid-soluble (crosses BBB), whereas Atenolol is water-soluble (low CNS side effects).

Q: Telmisartan lowers blood pressure by:

Blocking AT1 receptors. **Explanation:** **Telmisartan** belongs to the class of drugs known as **Angiotensin Receptor Blockers (ARBs)**. Its primary mechanism of action is the selective and competitive antagonism of the **Angiotensin II Type 1 (AT1) receptor**. By blocking these receptors, Telmisartan prevents the potent vasoconstriction, aldosterone secretion, and sympathetic activation normally induced by Angiotensin II, thereby lowering blood pressure. **Analysis of Options:** * **Option A (Inhibiting formation of Angiotensin II):** This describes the mechanism of **ACE Inhibitors** (e.g., Enalapril, Ramipril), which inhibit the Angiotensin-Converting Enzyme. * **Option B (Inhibiting conversion of Renin to Angiotensin I):** This describes the mechanism of **Direct Renin Inhibitors** (e.g., Aliskiren). * **Option D (Interfering with degradation of bradykinin):** This is a secondary effect of **ACE Inhibitors**. Because ARBs do not inhibit ACE, they do not increase bradykinin levels. This explains why ARBs are not typically associated with the dry cough or angioedema seen with ACE inhibitors. **High-Yield Clinical Pearls for NEET-PG:** * **Unique Property:** Telmisartan has the **longest half-life** (~24 hours) among ARBs, allowing for once-daily dosing. * **PPAR-γ Activity:** Unlike other ARBs, Telmisartan acts as a partial agonist of **PPAR-gamma**, which may provide additional metabolic benefits (improving insulin sensitivity). * **Uricosuric Effect:** While Telmisartan is standard, remember that **Losartan** is unique for its uricosuric property (useful in patients with gout). * **Contraindication:** Like ACE inhibitors, ARBs are strictly **contraindicated in pregnancy** (teratogenic) and in patients with bilateral renal artery stenosis.

Q: What is the primary pharmacological treatment for orthostatic hypotension?

Fludrocortisone. **Explanation:** **Correct Option: C. Fludrocortisone** Orthostatic hypotension (OH) is defined as a sustained reduction in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of 10 mmHg within 3 minutes of standing. **Fludrocortisone** is considered the first-line pharmacological treatment. It is a potent synthetic mineralocorticoid that works by increasing sodium and water reabsorption in the distal renal tubules. This expands the extracellular fluid (ECF) volume and increases the sensitivity of alpha-adrenergic receptors to circulating catecholamines, thereby maintaining blood pressure during postural changes. **Analysis of Incorrect Options:** * **A. Dopamine:** While dopamine is a vasopressor used in acute shock or severe bradycardia, it is administered intravenously and is not suitable for the chronic, long-term management of orthostatic hypotension. * **B. Diuretics:** These drugs promote the excretion of sodium and water, leading to volume depletion. Diuretics are a common *cause* of orthostatic hypotension, not a treatment. * **C. Calcium Channel Blockers (CCBs):** CCBs cause peripheral vasodilation and decrease systemic vascular resistance, which would further lower blood pressure and exacerbate orthostatic symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Non-pharmacological first step:** Increased salt intake, hydration, and use of compression stockings. * **Midodrine:** An alpha-1 agonist often used as an alternative or adjunct to fludrocortisone. * **Droxidopa:** A synthetic precursor of norepinephrine used specifically in neurogenic orthostatic hypotension. * **Side effect of Fludrocortisone:** Monitor for hypokalemia, supine hypertension, and peripheral edema.

Q: After using transdermal nitroglycerin skin patches for 1 week, a patient with an 8-month history of chronic stable angina pectoris observes an increasing frequency of mild angina episodes during exertion. The patient has been conscientiously applying a new patch every morning immediately after removing the old one. The patient's increased frequency of anginal attacks is most likely because of

Cellular tolerance to organic nitrates. **Explanation:** **1. Why the Correct Answer is Right:** The patient is experiencing **nitrate tolerance** (tachyphylaxis). Nitroglycerin works by releasing nitric oxide (NO), which requires intracellular **sulfhydryl (-SH) groups** and the enzyme **mitochondrial aldehyde dehydrogenase (ALDH2)**. Continuous exposure to nitrates (applying a new patch immediately after removing the old one) leads to: * Depletion of free sulfhydryl groups. * Inactivation of ALDH2. * Increased production of free radicals (oxidative stress) that inhibit guanylate cyclase. Because the patient maintained a constant 24-hour plasma concentration without a "nitrate-free interval," the drug lost its therapeutic efficacy, leading to the recurrence of anginal symptoms. **2. Why Incorrect Options are Wrong:** * **Option A:** Vasospastic (Prinzmetal) angina occurs due to coronary artery spasms at rest, not typically triggered by exertion, and wouldn't suddenly develop due to patch use. * **Option B:** While exercise triggers angina, the question specifies an *increasing frequency* despite medication use, pointing toward drug failure rather than a change in activity level. * **Option C:** Nitroglycerin is metabolized primarily by glutathione reductase and ALDH2, not by the CYP450 system. It does not act as an enzyme inducer. **3. NEET-PG High-Yield Pearls:** * **Nitrate-Free Interval:** To prevent tolerance, a daily drug-free period of **10–12 hours** (usually at night) is mandatory. * **Monday Disease:** Industrial workers exposed to nitrates lose tolerance over the weekend; re-exposure on Monday causes sudden vasodilation (headache/dizziness). * **Drug of Choice:** Sublingual Nitroglycerin is the DOC for **acute** anginal attacks; Transdermal patches/Isosorbide mononitrate are for **prophylaxis**. * **Contraindication:** Never co-administer with **Sildenafil** (PDE-5 inhibitors) due to the risk of severe, fatal hypotension.

Q: What is a known side effect of minoxidil that is also its therapeutic use?

Hair growth. **Explanation:** **Minoxidil** is a potent **K+ channel opener** that acts as a direct-acting vasodilator. By opening ATP-sensitive potassium channels in vascular smooth muscle, it causes hyperpolarization and relaxation of arterioles, leading to a significant drop in blood pressure. **Why "Hair growth" is correct:** A notable side effect of systemic minoxidil therapy is **hypertrichosis** (excessive hair growth on the face, arms, and back). This occurs because the drug increases blood flow to hair follicles and stimulates the transition of follicles from the resting (telogen) phase to the active (anagen) phase. This side effect was repurposed for the therapeutic treatment of **androgenetic alopecia** (male/female pattern baldness) via topical formulations (e.g., Rogaine). **Analysis of incorrect options:** * **A. Bradycardia:** Minoxidil causes profound vasodilation, which triggers a **reflex tachycardia** (not bradycardia) due to baroreceptor activation. It is often co-administered with a beta-blocker to counteract this. * **C. Gynecomastia:** This is a classic side effect of **Spironolactone** (a potassium-sparing diuretic), not minoxidil. * **D. Vasodilation:** While minoxidil does cause vasodilation, this is its **primary mechanism of action**, not a side effect. The question asks for a side effect that became a therapeutic use. **High-Yield Clinical Pearls for NEET-PG:** * **Fluid Retention:** Minoxidil causes significant salt and water retention (edema); it is usually prescribed with a loop diuretic (Furosemide). * **Black Box Warning:** It can cause **pericardial effusion** or tamponade in some patients. * **Indication:** Reserved for severe, refractory hypertension that does not respond to standard triple-drug regimens.

Question 1

Propranolol can be used in all of the following conditions except?

Accepted Answer

Variant angina

Answer

Thyrotoxicosis

Answer

Migraine

Answer

Hypertension

Question 2

Which of the following is a potassium channel opener?

Accepted Answer

Nicorandil

Answer

Ranolazine

Answer

Ivabradine

Answer

Nitroprusside

Question 3

Which of the following statements is NOT true regarding the use of beta-blockers in Congestive Heart Failure?

Accepted Answer

Beta-blockers are the drug of choice in acute decompensated heart failure.

Answer

Beta-blockers should be started at a very low dose and slowly titrated upwards.

Answer

Carvedilol is a widely used beta-blocker in CHF.

Answer

Beta-blockers can reduce mortality in CHF patients.

Question 4

Which of the following is the shortest acting beta-blocker?

Accepted Answer

Esmolol

Answer

Acebutolol

Answer

Sotalol

Answer

Bisoprolol

Question 5

Telmisartan lowers blood pressure by:

Accepted Answer

Blocking AT1 receptors

Answer

Inhibiting formation of angiotensin I to angiotensin II

Answer

Inhibiting conversion of renin to angiotensin I

Answer

Interfering with degradation of bradykinin

Question 6

What is the primary pharmacological treatment for orthostatic hypotension?

Accepted Answer

Fludrocortisone

Answer

Dopamine

Answer

Diuretics

Answer

Calcium channel blockers

Question 7

Which of the following statements is not true regarding ACE inhibitors?

Accepted Answer

Postural hypotension is a potential side effect.

Answer

They are used in asthma.

Answer

They can increase quality of life.

Answer

A decrease in sodium levels can be observed.

Question 8

After using transdermal nitroglycerin skin patches for 1 week, a patient with an 8-month history of chronic stable angina pectoris observes an increasing frequency of mild angina episodes during exertion. The patient has been conscientiously applying a new patch every morning immediately after removing the old one. The patient's increased frequency of anginal attacks is most likely because of

Accepted Answer

Cellular tolerance to organic nitrates

Answer

A sudden onset of vasospastic angina

Answer

Engaging in vigorous exercise

Answer

Induction of cytochrome P450 enzyme by nitroglycerin

Question 9

What is a known side effect of minoxidil that is also its therapeutic use?

Accepted Answer

Hair growth

Answer

Bradycardia

Answer

Gynecomastia

Answer

Vasodilation

Question 10

A 71-year-old woman, receiving a drug to lower her serum cholesterol, has developed muscle pain and weakness unrelated to physical activity over the past week. On examination, she has diffuse but mild muscle tenderness. Laboratory studies show her serum creatine kinase is 2049 U/L and creatinine is 2 mg/dL. Urine dipstick analysis is positive for blood, without RBCs on urine microscopy. Which of the following drugs is most likely to produce her findings?

Accepted Answer

Lovastatin

Answer

Cholestyramine

Answer

Clofibrate

Answer

Ezetimibe

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?